Atlas Trials

Repeated Intranasal Esketamine Plus Almond Therapy in Participants With Treatment Resistant Depressive Disorder - 3 Month Extension Study

Clinical trial NCT05438758 · WITHDRAWN

Trial details

NCT number
NCT05438758
Sponsor
Zylorion Health
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Treatment Resistant Major Depressive Disorder
Start date
2023-01-15
Primary completion
2024-02-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.